title: Preoperative nodal staging of non-small cell lung cancer using 99mTc-sestamibi spect/ct imaging.
abstract: OBJECTIVE
  The proper nodal staging of non-small cell lung cancer is important for choosing the best treatment modality. Although computed tomography remains the first-line imaging test for the primary staging of lung cancer, its limitations for mediastinum nodal staging are well known. The aim of this study is to evaluate the accuracy of hybrid single-photon emission computed tomography and computed tomography using 99mTc-sestamibi in the nodal staging of patients with non-small cell lung cancer and to identify potential candidates for surgical treatment.
  
  
  METHODS
  Prospective data were collected for 41 patients from December 2006 to February 2009. The patients underwent chest computed tomography and single-photon emission computed tomography/computed tomography examinations with 99mTc-sestamibi within a 30-day time period before surgery. Single-photon emission computed tomography/computed tomography was considered positive when there was focal uptake of sestamibi in the mediastinum, and computed tomography scan when there was lymph nodes larger than 10 mm in short axis. The results of single-photon emission computed tomography and computed tomography were correlated with pathology findings after surgery.
  
  
  RESULTS
  Single-photon emission computed tomography/computed tomography correctly identified six out of 19 cases involving hilar lymph nodes and one out of seven cases involving nodal metastases in the mediastinum. The sensitivity, specificity, positive predictive value, and negative predictive value for 99mTc-sestamibi single-photon emission computed tomography/computed tomography in the hilum assessment were 31.6%, 95.5%, 85.7%, and 61.8%, respectively. The same values for the mediastinum were 14.3%, 97.1%, 50%, and 84.6%, respectively. For the hilar and mediastinal lymph nodes, chest tomography showed sensitivity values of 47.4% and 57.1%, specificity values of 95.5% and 91.2%, positive predictive values of 90% and 57.1% and negative predictive values of 67.7% and 91.2%, respectively.
  
  
  CONCLUSIONS
  Single-photon emission computed tomography/computed tomography with 99mTc-sestamibi showed very low sensitivity and accuracy for the nodal staging of patients with non-small cell lung cancer, despite its high level of specificity. In addition, the performance of single-photon emission computed tomography/computed tomography added no relevant information compared to computed tomography that would justify its use in the routine preoperative staging of non-small cell lung carcinoma.
authors.affiliation: Hospital de Câncer de Barretos, Barretos, SP, Brazil. julimiziara@ig.com.br
authors.forename: Juliana Muniz
authors.initials: JM
authors.lastname: Miziara
authors.forename: Euclides Timóteo
authors.initials: ET
authors.lastname: da Rocha
authors.forename: José Elias Abrão
authors.initials: JE
authors.lastname: Miziara
authors.forename: Gustavo Fabene
authors.initials: GF
authors.lastname: Garcia
authors.forename: Maria Izilda Previato
authors.initials: MI
authors.lastname: Simões
authors.forename: Marco Antônio
authors.initials: MA
authors.lastname: Lopes
authors.forename: Lígia Maria
authors.initials: LM
authors.lastname: Kerr
authors.forename: Carlos Alberto
authors.initials: CA
authors.lastname: Buchpiguel
mesh_terms: D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000000981:diagnostic imaging* / Q000556:secondary; D004812:Epidemiologic Methods; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D008198:Lymph Nodes / Q000000981:diagnostic imaging; D008297:Male; D008482:Mediastinum / Q000000981:diagnostic imaging; D008875:Middle Aged; D009367:Neoplasm Staging / Q000379:methods; D011300:Preoperative Care / Q000009:adverse effects; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
chemical_list: D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi
references.citation: Eur J Cardiothorac Surg. 2009 Feb;35(2):325-31
references.pmid: 18996706
references.citation: Chest. 2002 Oct;122(4):1361-4
references.pmid: 12377865
references.citation: Cancer Res. 1995 Dec 1;55(23 Suppl):5759s-5763s
references.pmid: 7493342
references.citation: Chest. 2003 Jan;123(1 Suppl):137S-146S
references.pmid: 12527573
references.citation: Chest. 1997 Jun;111(6):1718-23
references.pmid: 9187199
references.citation: Radiol Med. 2006 Mar;111(2):213-24
references.pmid: 16671379
references.citation: Eur J Radiol. 2011 Sep;79(3):459-66
references.pmid: 20466499
references.citation: Thorax. 2000 Jan;55(1):60-2
references.pmid: 10607803
references.citation: Respiration. 2003 Sep-Oct;70(5):500-6
references.pmid: 14665776
references.citation: Radiology. 1991 Mar;178(3):705-13
references.pmid: 1847239
references.citation: Chest. 1997 Dec;112(6):1480-6
references.pmid: 9404742
references.citation: Clinics (Sao Paulo). 2009;64(12):1139-44
references.pmid: 20037700
references.citation: Chest. 2007 Sep;132(3 Suppl):202S-220S
references.pmid: 17873169
references.citation: Eur J Cardiothorac Surg. 2003 Mar;23(3):403-8
references.pmid: 12614814
references.citation: J Thorac Oncol. 2006 Jan;1(1):71-3
references.pmid: 17409830
references.citation: Chest. 1997 Jun;111(6):1710-7
references.pmid: 9187198
references.citation: Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5
references.pmid: 19464906
references.citation: J Nucl Med. 1990 Jul;31(7):1166-7
references.pmid: 2362196
references.citation: Clin Radiol. 2008 Mar;63(3):241-51
references.pmid: 18275863
references.citation: Eur J Cardiothorac Surg. 2009 Oct;36(4):731-6
references.pmid: 19632852
references.citation: J Nucl Med. 1996 Jun;37(6):938-42
references.pmid: 8683315